ESC 365 - Doctor Maria Angeles Alonso Garcia

Speaker illustration

Doctor Maria Angeles Alonso Garcia

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)

Member of:

Current positions: Senior Medical Assessor in the Medicines and Healthcare products Regulatory Agency (MHRA). Consultant in Cardiology. Imperial College Healthcare. NHS. United Kingdom. Dr Alonso graduated from the School of Medicine at the Universidad Autónoma de Madrid (1979). PhD at the Medical School (1991). Staff member of the Department of Cardiology Hospital Puerta de Hierro (Madrid), since 1987 until 2013 with several positions: Head of the Coronary Care Unit. Cardiologist consultant involved in clinical trials on Heart Failure, Ischaemic Heart Disease and Cardiovascular Prevention. Member of the Committee for Ethics and Clinical Investigation . General Secretary of the Spanish Society of Cardiology. Fellow of the European Society of Cardiology since 2001. Past Member of the ESC Clinical Guidelines Committee. Past Nucleus member of Cardiovascular Pharmacology Working Group. Past member of Scientific Advice Working Party at the European Medicines Agency (EMA) 2006-2019

Sessions Presentations

Designing trials

Event: HFA Clinical Trials in Heart Failure Course 2022

Topic: Heart Failure

Session type: Special Session

Controversies in Cardiovascular Disease Prevention: Statin for Primary Prevention at Age 75

Event: ESC Congress 2020

Topic: Risk Factors and Prevention

Session type: Debate Session

Lipids / Cardiovascular risk prediction / Life style

Event: ESC Congress 2019

Topic: Risk Factors and Prevention

Session type: Rapid Fire Abstracts

Translating new pharmacology science into clinical practice

Event: ESC Congress 2019

Topic: Pharmacology and Pharmacotherapy

Session type: Symposium

Meet the Experts - Safety first: avoiding adverse events with new cardiovascular drugs

Event: ESC Congress 2018

Topic: Cardiovascular Pharmacotherapy

Session type: Expert Session

Optimal surrogate endpoints of drug response

Event: ESC Congress 2018

Topic: Cardiovascular Pharmacotherapy

Session type: Moderated Posters

Therapeutic challenges in women

Event: ESC Congress 2017

Topic: Drug therapy

Session type: Symposium

Optimising cardiovascular pharmacotherapy

Event: ESC Congress 2017

Topic: Drug therapy

Session type: Rapid Fire Abstracts

Antiarrhythmic drugs in challenging arrhythmias

Event: ESC Congress 2017

Topic: Drug therapy

Session type: Symposium

Burning cases from recent Guidelines

Event: ESC Congress 2016

Topic: Guidelines and implementation in low resource settings

Session type: Guidelines in Practice

ESC 365 is supported by